🔗 Visit the ClinicalTrials.gov page for NCT01133704
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Novel therapies for metastatic castrate-resistant prostate cancer. | J Natl Cancer Inst | 2011 | 1.98 |
| 2 | A transient increase in eosinophils is associated with prolonged survival in men with metastatic castration-resistant prostate cancer who receive sipuleucel-T. | Cancer Immunol Res | 2014 | 0.93 |
| 3 | Time to disease-related pain and first opioid use in patients with metastatic castration-resistant prostate cancer treated with sipuleucel-T. | Prostate Cancer Prostatic Dis | 2014 | 0.86 |
| 4 | Targeted treatment of metastatic castration-resistant prostate cancer with sipuleucel-T immunotherapy. | Cancer Immunol Immunother | 2015 | 0.82 |
| 5 | Therapeutic cancer vaccines and combination immunotherapies involving vaccination. | Immunotargets Ther | 2014 | 0.75 |